Tackling “the Biggest Question That Everyone Is Asking” in Breast Cancer Care
About this episode
The episode discusses the current approaches to treating patients with ESR1-mutated advanced breast cancer and the use of oral selective estrogen receptor degraders.
How are oncologists currently approaching the care of patients with ESR1-mutated advanced breast cancer in practice? Erin Frances Cobain, MD, associate professor at the University of Michigan Rogel Cancer Center in Ann Arbor, speaks with Wassim Mchayleh, MD, MBA, the clinical program director of the breast cancer program at AdventHealth Cancer Institute and associate professor of medicine at the University of Central Florida in Orlando, about how to best use oral selective estrogen receptor degraders. “And the big question is ‘Can we use SERDs in combination, or are SERDs effective in patients without an ESR1 mutation?’ Can we go outside the current approved guidelines? And I think that’s the biggest question that everyone is asking today,” notes Dr. Mchayleh.
People in this episode
Host: Erin Frances Cobain, MD
Guest: Wassim Mchayleh, MD, MBA
Topics covered
- breast cancer
- ESR1 mutation
- oncology
- SERDs
- advanced breast cancer
- patient care
Keywords
- breast cancer
- ESR1 mutation
- SERDs
- oncology
- advanced breast cancer
- patient care
- treatment guidelines
Mentioned in this episode
Organizations: University of Michigan Rogel Cancer Center, AdventHealth Cancer Institute, University of Central Florida
More episodes of Oncology News Central Peer-Spectives
- New Targeted Therapies Make Breast Cancer Treatment Decisions “a Bit of a Moving Target”
- Advances in ESR1-Mutated Breast Cancer Care Lead to “Complex Situation” in Clinic
- Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC
- “Where the Real Answer Lies”: How CNS Disease Influences EGFR-Mutated NSCLC Treatment Decisions
- “Is the Juice Worth the Squeeze?”: Treatment Intensification for Advanced EGFRm NSCLC
- As Terminal Patients Live Longer, How Can Oncologists Help Them Cope With Uncertainty?
Explore listener stats, chart rankings, contacts and more on the Oncology News Central Peer-Spectives podcast page.